Immediate Limited Stop Service on Aequita Pharmacy LLC., which compounds Glucagon-like peptide-1s (GLP-1s) like Semaglutide, Tirzepatide

Having trouble viewing this email? View it as a Web page.

press release - washington medical commission

FOR IMMEDIATE RELEASE


Contact:
Department of Health PIO
[email protected]

Pharmacy Quality Assurance Commission issues Limited Stop Service on license of pharmacy

OLYMPIA – The Pharmacy Quality Assurance Commission (PQAC) has issued a Limited Stop Service to Aequita Pharmacy LLC (Aequita) pending further legal action. The pharmacy is located at 12825 NE 126th Place, Kirkland, WA 98034-7721 (PHAR.CF.61458335).

The notice of immediate Limited Stop Service alleges that Aequita, which compounds Glucagon-like peptide-1s (GLP-1s) such as Semaglutide and Tirzepatide, failed to develop and implement a commission-approved plan of correction to correct deficient practices or conditions. The deficient practices include allowing untrained and unqualified staff to perform sterile compounding, not properly supervising staff, and not adhering to sterile compounding procedures designed to ensure product integrity and patient safety.

Aequita cannot compound and cannot dispense, deliver, or distribute compounded products in Washington state until the Limited Stop Service is resolved. They have 28 days to respond to the Limited Stop Service by requesting a hearing. PQAC must conduct a follow-up inspection within five business days unless Aequita requests additional time.

Legal documents are available by clicking the link to Provider Credential Search on the agency home page (doh.wa.gov) or by calling 360-236-4700. Anyone who believes a health care facility or health care provider has violated licensing laws is encouraged to call 360-236-2620 to report their complaint. Complaints can also be submitted via email to [email protected].

###


  GovDelivery logo